S. Papadakos

发表

Investigating the Anticancer Potential of Salvicine as a Modulator of Topoisomerase II and ROS Signaling Cascade

S. Baral, M. Farzana, M. Rahman, 2022, Frontiers in Oncology.

The Role of the NLRP3 Inflammasome in HCC Carcinogenesis and Treatment: Harnessing Innate Immunity

Stamatios A. Theocharis, E. Kouroumalis, S. Papadakos, 2022, Cancers.

The EPH/Ephrin System in Colorectal Cancer

S. Theocharis, L. Petrogiannopoulos, S. Papadakos, 2022, International journal of molecular sciences.

Hepatomusculoskeletal disorders: Coining a new term might improve the management of the musculoskeletal manifestations of chronic liver disease

C. Tsagkaris, A. Papazoglou, D. Moysidis, 2022, World journal of gastrointestinal pathophysiology.

Pill versus vaccine for COVID-19: Is there a genuine dilemma?

C. Tsioutis, N. Spernovasilis, S. Papadakos, 2021, Ethics, Medicine and Public Health.

Angiogenesis in gastrointestinal stromal tumors: From bench to bedside

S. Theocharis, C. Tsagkaris, A. Papazoglou, 2022, World journal of gastrointestinal oncology.

Nanotherapy based on magneto-mechanochemical modulation of tumor redox state.

V. Orel, C. Tsagkaris, D. Moysidis, 2022, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

Onodera's prognostic nutritional index: Comparison of its role in the severity and outcomes of patients with COVID‑19 during the periods of alpha, delta and omicron variant predominance.

D. Spandidos, George Fotakopoulos, P. Papalexis, 2022, Experimental and therapeutic medicine.

Cordycepin as a Promising Inhibitor of SARS-CoV-2 RNA dependent RNA polymerase (RdRp).

Hong Yu, Yuanbing Wang, Mohammad Mehedi Hasan, 2021, Current medicinal chemistry.

Candidate antiviral drugs for COVID-19 and their environmental implications: a comprehensive analysis

M. M. Hasan, M. Uddin, Md. Hasanur Rahman, 2021, Environmental Science and Pollution Research.

The EPH/Ephrin System in Pancreatic Ductal Adenocarcinoma (PDAC): From Pathogenesis to Treatment

S. Theocharis, N. Machairas, S. Papadakos, 2023, International journal of molecular sciences.

Exosomes in the Treatment of Pancreatic Cancer: A Moonshot to PDAC Treatment?

M. Gazouli, S. Theocharis, S. Papadakos, 2022, International journal of molecular sciences.

Glycemic control and atrial fibrillation: an intricate relationship, yet under investigation

G. Giannakoulas, C. Tsagkaris, A. Papazoglou, 2022, Cardiovascular Diabetology.

COVID-19 and liver injury in individuals with obesity

George Fotakopoulos, P. Papalexis, V. Lekakis, 2023, World journal of gastroenterology.

The Role of TLR4 in the Immunotherapy of Hepatocellular Carcinoma: Can We Teach an Old Dog New Tricks?

S. Theocharis, G. Germanidis, V. Lekakis, 2023, Cancers.

Biomarkers predicting the 30‑day mortality of patients who underwent elective surgery and were infected with SARS‑CoV‑2 during the post‑operative period: A retrospective study

D. Spandidos, George Fotakopoulos, P. Papalexis, 2022, Experimental and therapeutic medicine.

Unraveling the Significance of EPH/Ephrin Signaling in Liver Cancer: Insights into Tumor Progression and Therapeutic Implications

N. Muhammad, S. Theocharis, I. Stergiou, 2023, Cancers.

The Emerging Role of Metformin in the Treatment of Hepatocellular Carcinoma: Is There Any Value in Repurposing Metformin for HCC Immunotherapy?

S. Theocharis, A. Frampton, D. Schizas, 2023, Cancers.

Clinical and Oncological Impact of the Toll-like Receptor-3 and -4 in Esophageal and Gastro-esophageal Junction Adenocarcinoma

A. Charalabopoulos, D. Ziogas, T. Liakakos, 2023, AntiCancer Research.

EPH/Ephrin Signaling in Normal Hematopoiesis and Hematologic Malignancies: Deciphering Their Intricate Role and Unraveling Possible New Therapeutic Targets

O. Tsitsilonis, S. Theocharis, I. Stergiou, 2023, Cancers.

Nutraceuticals in the Work of Scribonius Largus, a Pioneer of Clinical Pharmacy in Ancient Rome

C. Tsagkaris, A. Loudovikou, S. Papadakos, 2022, Indo global journal of pharmaceutical sciences.

Unveiling the Yin-Yang Balance of M1 and M2 Macrophages in Hepatocellular Carcinoma: Role of Exosomes in Tumor Microenvironment and Immune Modulation

S. Theocharis, A. Frampton, G. Germanidis, 2023, Cells.

Meeting at the Crossroad between Obesity and Hepatic Carcinogenesis: Unique Pathophysiological Pathways Raise Expectations for Innovative Therapeutic Approaches

T. Koufakis, I. Stergiou, V. Georgakopoulou, 2023, International journal of molecular sciences.

The Clinical Impact of Death Domain-Associated Protein and Holliday Junction Recognition Protein Expression in Cancer: Unmasking the Driving Forces of Neoplasia

I. Stergiou, S. Papadakos, Alexandros Pergaris, 2023, Cancers.

Unusual Presentation of an Uncommon Malignancy: A 74-Year-Old Woman with Aggressive Fibromatosis of the Large Intestine Presenting as a Liver Mass and the Therapeutic Management

M. Karamouzis, J. Griniatsos, P. Sarantis, 2023, The American journal of case reports.

Unraveling the Role of the NLRP3 Inflammasome in Lymphoma: Implications in Pathogenesis and Therapeutic Strategies

O. Tsitsilonis, I. Stergiou, S. Papadakos, 2024, International journal of molecular sciences.

PD-L1 Expression in Neoplastic and Immune Cells of Thymic Epithelial Tumors: Correlations with Disease Characteristics and HDAC Expression

Georgia Levidou, I. Stergiou, C. Masaoutis, 2024, Biomedicines.

Metformin in Esophageal Carcinoma: Exploring Molecular Mechanisms and Therapeutic Insights

D. Schizas, T. Koufakis, I. Stergiou, 2024, International journal of molecular sciences.

Shedding light on the role of LAG-3 in hepatocellular carcinoma: unraveling immunomodulatory pathways

I. Stergiou, G. Kalopitas, S. Papadakos, 2024, Hepatoma Research.

Pathophysiology and Clinical Management of Dyslipidemia in People Living with HIV: Sailing through Rough Seas

K. Kotsa, O. Tsachouridou, T. Koufakis, 2024, Life.

Management of type 2 diabetes in patients with compensated liver cirrhosis: Short of evidence, plenty of potential.

K. Kotsa, T. Koufakis, G. Kalopitas, 2023, Diabetes & metabolic syndrome.

Understanding the Role of Connexins in Hepatocellular Carcinoma: Molecular and Prognostic Implications

I. Stergiou, S. Papadakos, M. Koutsompina, 2024, Cancers.

The Clinical Relevance of the EPH/Ephrin Signaling Pathway in Pediatric Solid and Hematologic Malignancies

I. Stergiou, S. Papadakos, Stamatios Theocharis, 2024, International journal of molecular sciences.

Exploring the Role of GITR/GITRL Signaling: From Liver Disease to Hepatocellular Carcinoma

S. Siakavellas, S. Manolakopoulos, T. Koufakis, 2024, Cancers.

Interplay of Extracellular Vesicles and TLR4 Signaling in Hepatocellular Carcinoma Pathophysiology and Therapeutics

C. Vallilas, I. Stergiou, S. Papadakos, 2023, Pharmaceutics.

γδ T Cells: A Game Changer in the Future of Hepatocellular Carcinoma Immunotherapy

I. Stergiou, S. Papadakos, M. Koutsompina, 2024, International journal of molecular sciences.